Welcome to CLEAR Cannabis Law Reform, the UK’s largest membership-based cannabis policy group.

Join Now

Taxing the UK Cannabis Market

The most authoritative, independent, expert research on the UK cannabis market by the Independent Drug Monitoring Unit, commissioned by CLEAR in 2011.

Medicinal Cannabis: The Evidence

The most up-to-date, analysis of the evidence on the safety and efficacy of cannabis as medicine. Focuses on Alzheimer’s disease, cancer, chronic pain, Crohn’s disease and multiple sclerosis. Published April 2015.

How To Regulate Cannabis In Britain

This is the second version of a plan for the regulation of the cannabis supply chain in Britain. This version was published on 18th October 2013

Follow Us On Social Media

Facebook

CLEAR Cannabis Law Reform

CLEAR does not advocate, condone, or encourage breaking the law. It exists to promote a change in the law by legitimate means. All information on this website should be viewed in this context.
CLEAR Cannabis Law Reform
CLEAR Cannabis Law Reform21 ago
"Through discovering the links between exercise and the endocannabinoid system, the goal is to develop new treatments for mental health conditions that include exercise. Meyer is currently recruiting 20-to-60-year-old men and women to participate in the study and says understanding the link between mood, exercise and the endocannabinoid system could lead to better treatment options."
CLEAR Cannabis Law Reform
CLEAR Cannabis Law Reform39 ago
“There’s clearly a need to develop alternatives for relief of acute and chronic pain that go beyond opioids. These molecules are non-psychoactive and they target the inflammation at the source, making them ideal painkillers.”
CLEAR Cannabis Law Reform
CLEAR Cannabis Law Reform1 hour ago
“Among the limited number of product characteristics that are typically made available to consumers, we found that consumption of whole, natural cannabis flower was associated with greater anaesthetic potential than were most other types of products.”
CLEAR Cannabis Law Reform
CLEAR Cannabis Law Reform1 hour ago
"GW Pharma’s Epidyolex for two types of severe treatment-resistant epilepsy has been given a preliminary rejection by England’s NICE – but the cost effectiveness watchdog has pledged to work with the company to resolve shortfalls in its data. In the US, the oral liquid product costs $32,500 for a year's worth of treatment. The company hasn't confirmed its UK list price yet, but NICE has already questioned its cost modelling for treatment."
CLEAR Cannabis Law Reform
CLEAR Cannabis Law Reform2 hours ago
"A butcher from southern France is enjoying unexpected commercial success after creating what he believes to be the world’s first cannabis-infused sausage. Luca Morand, 22, from Marseilles, said he sold 30kg within three days of putting them in his shop this month. “I’d never sold so many sausages so quickly,” he added."
CLEAR Cannabis Law Reform
CLEAR Cannabis Law Reform3 hours ago
"Drug traffickers thrive on their ability to penetrate national borders, but a new era of toxic, man-made highs could dissolve those boundaries and transform the global drug trade."

Twitter

2 hours ago
If you want safe, legal #CBD products which are exactly what they say on the tin, then look for the CannaPro badge or choose one of the certified businesses listed here: #cannabis #EndOurPain https://t.co/M9zdlwjO2q https://t.co/onUNmd05Ni CLEARUK photo
2 hours ago
Bangers with #cannabis put French butcher on a high. €50 a kilo, or about €4.50 per sausage #CBD https://t.co/efpdV0SNo3 https://t.co/RCuv1prqPM CLEARUK photo